one should differentiate between the thrombolytic activity , responsible for the efficacy of the drug on thrombosis and the systemic fibrinolytic activity , inducing the decrease in fibrinogen and coagulation factors which probably contribute as to the risk of bleeding , mostly related to invasive explorations ( arterial punctures , catheters ... ) , but possibly spontaneous .
C0016006
fibrinogen
C0019080
bleeding